AxoGen, Inc. (AXGN)
NASDAQ: AXGN · IEX Real-Time Price · USD
6.01
-0.55 (-8.46%)
May 2, 2024, 1:00 PM EDT - Market open

AxoGen Revenue

In the year 2023, AxoGen had annual revenue of $159.01M with 14.74% growth. Revenue in the quarter ending December 31, 2023 was $42.92M with 18.69% year-over-year growth.

Revenue (ttm)
$159.01M
Revenue Growth
+14.74%
P/S Ratio
1.65
Revenue / Employee
$373,268
Employees
426
Market Cap
262.45M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023159.01M20.43M14.74%
Dec 31, 2022138.58M11.23M8.81%
Dec 31, 2021127.36M15.06M13.41%
Dec 31, 2020112.30M5.59M5.24%
Dec 31, 2019106.71M22.78M27.13%
Dec 31, 201883.94M23.51M38.91%
Dec 31, 201760.43M19.32M46.99%
Dec 31, 201641.11M13.78M50.41%
Dec 31, 201527.33M10.51M62.52%
Dec 31, 201416.82M5.87M53.62%
Dec 31, 201310.95M3.26M42.33%
Dec 31, 20127.69M2.84M58.61%
Dec 31, 20114.85M1.85M61.41%
Dec 31, 20103.00M-21.91M-87.94%
Dec 31, 200924.91M24.84M34,160.81%
Dec 31, 200872.71K-27.72K-27.60%
Dec 31, 2007100.43K-26.23K-20.71%
Dec 31, 2006126.66K-316.69K-71.43%
Dec 31, 2005443.35K-621.65K-58.37%
Dec 31, 20041.07M--
Dec 31, 20030--
Dec 31, 20026.85M-8.11M-54.19%
Dec 31, 200114.96M1.54M11.49%
Jun 30, 200013.42M1.14M9.26%
Jun 30, 199912.28M-643.29K-4.98%
Jun 30, 199812.92M666.04K5.43%
Jun 30, 199712.26M-844.43K-6.45%
Jun 30, 199613.10M-1.04M-7.34%
Jun 30, 199514.14M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
GeneDx Holdings 202.57M
Sight Sciences 81.06M
Pulmonx 68.68M
Lyra Therapeutics 1.56M
Inovio Pharmaceuticals 832.01K
Revenue Rankings